Skip to main content
SpringerLink
Log in

The Influence of Ill-Health Experience on the Valuation of Health

  • Original Research Article
  • Ill-Health Experience and Health Valuation
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

Social valuations for health states are potentially useful both in clinical decision- making and in health-resource allocation, but there is some evidence that the experience of illness may affect such valuations. This article compares valuations of hypothetical health states obtained from a sample of chronically ill patients, with valuations obtained from a sample of relatively healthy individuals. The instrument used to obtain these values was the EuroQOL 5D questionnaire (EQ-5D).

We found that the EQ-5D values of chronically ill patients differed significantly from the values obtained from healthier individuals, particularly in the case of the more severe health states. Healthy individuals assigned negative values to some hypothetical health states, indicating that they consider them to be worse than death, whereas chronically ill patients assigned positive values to all health states.

These results raise difficult questions about whose values should count when health-status measures are incorporated in clinical and economic evaluation, and in particular when deciding upon the allocation of scarce resources.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kind P, Gudex CM. Measuring health status in the community: a comparison of methods. J Epidemiol Community Health 1994; 48: 86–91

    Article  PubMed  CAS  Google Scholar 

  2. Patrick DL, Erickson P. Health status and health policy. Oxford: Oxford University Press, 1993: 50

    Google Scholar 

  3. Nord E. Methods for quality adjustment of life years. Soc Sci Med 1992; 34: 559–69

    Article  PubMed  CAS  Google Scholar 

  4. Churchill DN, Torrance GW, Taylor DW, et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 1987; 10: 14–20

    PubMed  CAS  Google Scholar 

  5. Ashby J, O’Hanlon M, Buxton M. The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups? Qual Life Res 1994; 3: 257–65

    Article  PubMed  CAS  Google Scholar 

  6. Patrick DL, Starks H, Cain KC, et al. Measuring preferences for health states worse than death. Med Decis Making 1994; 14: 9–18

    Article  PubMed  CAS  Google Scholar 

  7. Brooks R,EuroQol Group. EuroQol: the current state of play. Health Policy 1996; 37: 53–72

    Article  PubMed  CAS  Google Scholar 

  8. Kind P, Dolan P. The effect of past and present illness experience on the valuations of health states. Med Care 1995; 33 Suppl. 4: AS255–63

    Google Scholar 

  9. Selai C, Rosser R. Eliciting EuroQol descriptive data and utility scale values from inpatients. Pharmacoeconomics 1995; 8 (2): 147–158

    Article  PubMed  CAS  Google Scholar 

  10. Hurst NP, Jobanputra P, Hunter M, et al. Validity of EuroQol — a generic health status instrument — in patients with rheumatoid arthritis. Br J Rheumatol 1994; 33: 655–62

    Article  PubMed  CAS  Google Scholar 

  11. Badia X, Fernández E, Segura A. Influence of sociodemographic and health status variables on evaluation of health states in a Spanish population. Eur J Public Health 1995; 5: 87–93

    Article  Google Scholar 

  12. Armitage B. Statistical methods in medical research. 2nd ed. Oxford: Blackwell Scientific Publications, 1987: 7

    Google Scholar 

  13. Cohen J. Statistical power analyses for the behavioural sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum Associates, 1988

    Google Scholar 

  14. Balaban DJ, Sagi PC, Goldfarb NI, et al. Weights for scoring the quality of well being instrument among rheumatoid arthritics: a comparison to general population weights. Med Care 1986; 973–80

    Google Scholar 

  15. Patrick DL, Erickson P. Health status and health policy. Oxford: Oxford University Press, 1993: 360–5

    Google Scholar 

  16. Nord E, Badia X, Rué M, et al. Hypothetical valuations of health states versus patients’ self-ratings. In: Badia X, Herdman M, Segura A, editors. 1995 EuroQol plenary meeting discussion papers. Barcelona: Institut Universitari de Salut Pública de Catalunya, 1996: 99–112

    Google Scholar 

  17. Dolan P, Kind P. Inconsistency and health state valuations. Soc Sci Med 1996; 4: 609–15

    Article  Google Scholar 

  18. Gudex C, Dolan P, Kind P, et al. Health state valuations from the general public using the visual analogue scale. Qual Life Res 1996; 6: 521–31

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut de Salut Pública de Catalunya, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain

    Xavier Badia & Michael Herdman

  2. Centre for Health Economics, University of York, York, England

    Paul Kind

Authors
  1. Xavier Badia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Herdman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul Kind
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xavier Badia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Badia, X., Herdman, M. & Kind, P. The Influence of Ill-Health Experience on the Valuation of Health. Pharmacoeconomics 13, 687–696 (1998). https://doi.org/10.2165/00019053-199813060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199813060-00005

Keywords

Search

Navigation